Cargando…
A novel dressing seeded with embryonic artery CD133(+) cells and loaded with the Sirt1 agonist SRT1720 accelerates the healing of diabetic ischemic ulcers
Refractory ischemic ulcers that occur in patients with diabetes present a major clinical challenge. Embryonic artery cluster of differentiation 133(+) cells (EACCs) may promote the healing of diabetic ulcers; however, the high glucose environment in the diabetic ulcers decreases the survival rate of...
Autores principales: | Cheng, Pan-Ke, Chen, Xiao-Long, Su, Xing-Xing, Su, Xue-Jiao, Hou, Chun-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996715/ https://www.ncbi.nlm.nih.gov/pubmed/29904408 http://dx.doi.org/10.3892/etm.2018.6099 |
Ejemplares similares
-
SRT2183 and SRT1720, but not Resveratrol, Inhibit Osteoclast Formation and Resorption in the Presence or Absence of Sirt1
por: Thiyagarajan, Ramkumar, et al.
Publicado: (2023) -
SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson's disease
por: Chao, Chih-Chang, et al.
Publicado: (2022) -
Intraperitoneal injection of the SIRT1 activator SRT1720 attenuates the progression of experimental osteoarthritis in mice
por: Nishida, K., et al.
Publicado: (2018) -
SRT1720 improves survival and healthspan of obese mice
por: Minor, Robin K., et al.
Publicado: (2011) -
CORRIGENDUM: SRT1720 improves survival and healthspan of obese mice
por: Minor, Robin K., et al.
Publicado: (2013)